|
You are invited to attend a webinar discussing how rebate walls don’t benefit patients, and explore reforms to expand patient access to cheaper alternatives and lower out-of-pocket costs
Join Dr. Wayne Winegarden, director of the Center for Medical Economics and Innovation at the Pacific Research Institute – a California-based, nonpartisan, free-market think tank – for a discussion on how the current drug rebate system fails patients by increasing their out-of-pocket medical costs.
Dr. Winegarden will discuss the findings of his new brief, “Tear Down These Walls,” which documents how “rebate walls” effectively block patient access to competitive, lower-priced medicines in favor of medications offering the largest rebates. He shows that this lack of competition between drugs causes prices to remain high and imposes excessive costs on patients who require expensive medications.
He will outline free-market policy reforms to expand competition, increase patient access to more affordable alternative medications, and lower patient out-of-pocket costs. A Q&A session will follow Dr. Winegarden’s presentation. Additional speakers to be announced.
About Dr. Wayne Winegarden
Wayne Winegarden, Ph.D., is a Sr. Fellow in Business &  Economics, Pacific Research Institute, as well as the Director of PRI’s Center for Medical Economics and Innovation.
Dr. Winegarden’s policy research explores the connection between macroeconomic policies and economic outcomes, with a focus on fiscal policy, the health care industry, and the energy sector. As Director of the Center for Medical Economics and Innovation, Dr. Winegarden spearheads research and advances policies that support the continued viability and vitality of the U.S. biomedical and pharmaceutical industries to the benefit of patients and overall economic growth.
Dr. Winegarden’s columns have been published in the Wall Street Journal, Chicago Tribune, Investor’s Business Daily, Forbes.com, and USA Today. He was previously economics faculty at Marymount University, has testified before the U.S. Congress, has been interviewed and quoted in such media as CNN and Bloomberg Radio, and is asked to present his research findings at policy conferences and meetings.
Dr. Winegarden is also the Principal of an economic advisory firm that advises clients on the economic, business, and investment implications from changes in broader macroeconomic trends and government policies. Clients have included Fortune 500 companies, financial organizations, small businesses, and trade associations. Previously, Dr. Winegarden worked as a business economist in Hong Kong and New York City; and a policy economist for policy and trade associations in Washington D.C. Dr. Winegarden received his B.A., M.A., and Ph.D. in Economics from George Mason University.
|
